apremilast,deucravacitinib
bms,amgen
['deucra', 'poetyk,pso-1', 'poetyk,pso-2']
congress #wcd2023singapore | mark lebwohl presents long-term efficacy results of deucravacitinib in pts with plaque #psoriais from ph3 poetyk pso-1 &amp; pso-2 trials. n=513. 313 pts were pasi 75 responders at w16. at w112, mnri response rates for pasi 75, pasi 90 &amp; 
The Psoriasis and Psoriatic Arthritis Hub is an open-access online resource that provides balanced and up-to-date medical education. #Psoriasis #RheumTwitter